Holding(s) in Company
December 10 2008 - 11:10AM
UK Regulatory
RNS Number : 9068J
Osmetech PLC
10 December 2008
Form TR-1 with annex. FSA Version 2.1 updated April 2007
For filings with the FSA include the annex
For filings with issuer exclude the annex
TR-1: Notifications of Major Interests in Shares
Osmetech
1. Identity of the issuer or the underlying issuer
of existing shares to which voting rights are
attached:
2. Reason for notification (yes/no)
Yes
An acquisition or disposal of voting rights
An acquisition or disposal of financial instruments which may result in
the acquisition of shares already issued to which voting rights are
attached
An event changing the breakdown of voting rights
Other (please specify):______________
Polar Capital Healthcare Opportunities Fund
3. Full name of person(s)
subject to notification
obligation:
4. Full name of shareholder(s)
(if different from 3):
5th December 2008
5. Date of transaction (and
date on which the threshold is
crossed or reached if
different):
9th December 2008
6. Date on which issuer
notified:
3%, 4%, 5%
7. Threshold(s) that is/are
crossed or reached:
8: Notified Details
A: Voting rights attached to shares
Class/type of shares Situation previous to the triggering Resulting situation after the triggering transaction
If possible use ISIN code transaction
Number of shares Number of voting Number of shares Number of voting Percentage of voting
rights rights rights
Direct Indirect Direct Indirect
B0K29R5 2,000,000 24,800,660 5.576%
B: Financial Instruments
Resulting situation after the triggering transaction
Type of financial instrument Expiration date Exercise/ conversion No. of voting rights Percentage of voting
period/date that may be acquired rights
(if the instrument
exercised/converted)
Total (A+B)
Number of voting rights Percentage of voting rights
24,800,660 5.576%
9. Chain of controlled undertakings through which the voting rights and /or
the financial instruments are effectively held, if applicable:
Proxy Voting:
10. Name of proxy holder:
11. Number of voting rights proxy holder will cease to hold:
12. Date on which proxy holder will cease to hold voting rights:
13. Additional information:
14 Contact name: Polar Capital LLP - Operations Department
15. Contact telephone name: +44 (0)207 227 2700
For notes on how to complete form TR-1 please see the FSA website.
Note: Annex should only be submitted to the FSA not the issuer
Annex: Notification of major interests in shares
A: Identity of the persons or legal entity subject to the notification
obligation
Full name Polar Capital Healthcare Opportunities
(including legal form of legal Fund
entities)
Contact address c/o Northern Trust International Fund
(registered office for legal entities) Administration Services
54-62 Townsend Street
Dublin 2
Ireland
Phone number & email +44 (0) 207 227 2700
operations@polarcapital.co.uk
Other useful information
(at least legal representative for
legal persons)
B: Identity of the notifier, if applicable
Full name Gopal Bharj
Contact address Polar Capital LLP
4 Matthew Parker
street
London SW1H 9NP
Phone number & email +44 (0)207 227 2700
Other useful information
(e.g. functional relationship with the person or
legal entity subject to the notification
obligation)
C: Additional information
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLFFIFISSASEIE
Osmetech (LSE:OMH)
Historical Stock Chart
From Jun 2024 to Jul 2024
Osmetech (LSE:OMH)
Historical Stock Chart
From Jul 2023 to Jul 2024
